Soltis Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Soltis Investment Advisors's AMGN Position: Q2 2026 in Review
Soltis Investment Advisors increased its Amgen (AMGN) stake by 7% in Q2 2026, buying an estimated $657K and bringing the position to 29,172 shares worth $10.6M. The position accounts for 0.59% of the portfolio, ranked #36.
Soltis Investment Advisors first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Soltis Investment Advisors held 29,172 shares of Amgen worth $10.6M as of Q2 2026.
- Soltis Investment Advisors bought 1,920 Amgen shares in Q2 2026, an estimated $657K.
- Amgen made up 0.59% of Soltis Investment Advisors's portfolio in Q2 2026, its #36 holding.
- Soltis Investment Advisors first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.